Semaglutide vs Tirzepatide
Overview
Semaglutide and Tirzepatide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Semaglutide and Tirzepatide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Semaglutide | Tirzepatide | |
|---|---|---|
| Category | Weight Management & Metabolic | Weight Management & Metabolic |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 0.25-2.4 mg | 2.5-15 mg |
| Frequency | weekly | weekly |
| Reported benefits | Significant weight loss, improved blood sugar control, reduced cardiovascular risk, appetite suppression | Enhanced weight loss, improved insulin sensitivity, better glycemic control, cardiovascular benefits |
| Reported side effects | Nausea, vomiting, diarrhea, constipation, potential pancreatitis risk | Similar to semaglutide: GI disturbances, nausea, potential pancreatitis |
Key differences
Primary use. Semaglutide is categorised under Weight Management & Metabolic, while Tirzepatide falls under Weight Management & Metabolic. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Semaglutide: FDA-approved. Tirzepatide: FDA-approved.
Dosing. Semaglutide is typically dosed at 0.25-2.4 mg (weekly). Tirzepatide is typically dosed at 2.5-15 mg (weekly).
Can you stack them?
Some protocols combine peptides, but stacking Semaglutide and Tirzepatide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Semaglutide and Tirzepatide?
- Semaglutide and Tirzepatide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status. Semaglutide is FDA-approved for one or more indications, whereas Tirzepatide is FDA-approved for one or more indications.
- What is Semaglutide used for?
- Weight loss, blood sugar control.
- What is Tirzepatide used for?
- Dual GIP/GLP-1 agonist for weight loss.
- Can you take Semaglutide and Tirzepatide together?
- Some users combine peptides within a single protocol, but stacking Semaglutide and Tirzepatide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Semaglutide or Tirzepatide FDA-approved?
- Semaglutide is FDA-approved for one or more indications. Tirzepatide is FDA-approved for one or more indications.
Read the full articles
- Semaglutide — full monograph: mechanism, research, dosing & references
- Tirzepatide — full monograph: mechanism, research, dosing & references